Business
Optima Health plc - Full Year Trading Update
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain. Optima Health plc(“Optima”, the “Company”, and, together with its subsidiaries, the
About this update from Optima Health Plc
[{"type":"image","alt":"Optima Health","displaySize":"","headline":null,"caption":"Optima Health","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":129,"url":"https://media.zenfs.com/en/globenewswire.com/05bca9da1ff168d406d0442fef16edb2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/e8RJDU6Xj60NA0Ez8X0FvA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE4MTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/05bca9da1ff168d406d0442fef16edb2","width":300,"height":129}},"lazy":false},{"type":"text","content":"The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.","length":415,"tagName":"p"},{"type":"text","content":"Optima Health plc(“Optima”, the “Company”, and, together with its subsidiaries, the “Group”)","length":93,"tagName":"p"},{"type":"text","content":"Full Year Trading Update","length":24,"tagName":"p"},{"type":"text","content":"LONDON, UK, 12 May 2025, Optima Health (AIM: OPT), the UK’s leading provider of technology enabled corporate health and wellbeing solutions, today announces its unaudited trading update ahead of publication of the Group’s full year results for the year ended 31 March 2025. All data is preliminary and subject to audit.","length":319,"tagName":"p"},{"type":"text","content":"Highlights","length":10,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Strong performance in the year with revenue of approximately £105 million; in line with market expectations ","length":107,"tagName":"p"}]},{"val":[{"type":"text","content":"Expected to deliver FY25 adjusted EBITDA in line with market expectations","length":73,"tagName":"p"}]},{"val":[{"type":"text","content":"Significant organic and inorganic progress made, growing Optima’s presence in its core UK market and expanding into a new territory; well positioned for strong growth in FY26","length":174,"tagName":"p"}]},{"val":[{"type":"text","content":"Robust balance sheet with net debt (excluding leases) of £2.2 million as at 31 March 2025","length":89,"tagName":"p"}]},{"val":[{"t...